Urethritis Follow-up
- Author: Martha K Terris, MD, FACS; Chief Editor: Edward David Kim, MD, FACS more...
Further Outpatient Care
- Only patients who remain symptomatic require follow-up cultures to ensure eradication of infection.
- If symptoms persist following adequate treatment, the disease is most likely nongonococcal urethritis (NGU). Prior to improved culture methods and increased awareness of the causes of NGU, symptom recurrences were thought to be psychological in nature. This is usually not the case, and most cases of recurrent NGU are related to persistent chlamydial, ureaplasmal, or mycoplasmal infection. These patients benefit from prolonged (14-28 d) therapy with erythromycin. Consider also quinolone resistance in gonococcal urethritis, based on local epidemiologic data.
- Most infections after treatment are due to reinfection by the same or a new partner, stressing the need to educate patients and to treat partners.
Deterrence/Prevention
- Educate at-risk patients on how to prevent disease recurrence.
- Educate patients on risks of other sexually-transmitted infections, including HIV.
- Try to find asymptomatic patients and symptomatic patients who are unlikely to seek treatment.
- Early diagnosis and treatment of infected individuals is essential.
- Evaluate and treat sexual partners of known infected persons.
Complications
- Complications, such as stricture, stenosis, or abscess formation, are quite rare. Concomitant epididymitis or prostatitis is not uncommon.
- PID and tubo-ovarian abscess are known complications of urethritis in females that may predispose to infertility. In addition, increasing evidence shows that genital chlamydial infection in males may predispose to infertility. In addition, both Chlamydia and U urealyticum can impair sperm and adversely affect semen parameters.[2, 3]
Prognosis
- All patients with uncomplicated urethritis spontaneously recover with or without treatment.
Patient Education
- Instruct patients to avoid the following high-risk behaviors are associated with STDs:
- Intercourse at a young age, with rare exception, is associated with multiple sex partners and unprotected intercourse.
- Intercourse with multiple partners
- Drug abuse
- Unprotected sex
- Intercourse with partners known to have infections
- Instruct patients to use barrier devices with all partners at all times.
- For excellent patient education resources, visit eMedicine's Kidneys and Urinary System Center and Pregnancy and Reproduction Center. Also, see eMedicine's patient education articles Urinary Tract Infections, Birth Control Spermicides, Birth Control FAQs, and Birth Control Overview.
Johnson LF, Lewis DA. The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis. Sex Transm Dis. Nov 2008;35(11):946-59. [Medline].
Bradshaw CS, Chen MY, Fairley CK. Persistence of Mycoplasma genitalium following azithromycin therapy. PLoS ONE. 2008;3(11):e3618. [Medline].
Gunn RA, O'Brien CJ, Lee MA, Gilchick RA. Gonorrhea screening among men who have sex with men: value of multiple anatomic site testing, San Diego, California, 1997-2003. Sex Transm Dis. Oct 2008;35(10):845-8. [Medline].
Anagrius C, Lore B, Jensen JS. Mycoplasma genitalium: prevalence, clinical significance, and transmission. Sex Transm Infect. Dec 2005;81(6):458-62. [Medline].
Frenkl T and Potts J. Sexually Transmitted Diseases. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, eds. Campbell-Walsh Urology. 9th ed. Philadelphia, Pa: Saunders; 2006:371-85.
Centers for Disease Control and Prevention. CDC Division of AIDS, STD, and TB. Gonococcal Isolation Surveillance Project (GISP) Annual Report - 2007. Atlanta, Ga: Centers for Disease Control and Prevention. [Full Text].
[Guideline] Centers for Disease Control and Prevention, Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep. Aug 4 2006;55:1-94. [Medline].
Chorba T, Tao G, Irwin K. Sexually Transmitted Diseases. In: Litwin MS, Saigal CS, eds. Urologic Diseases in America. 2004;233-79. [Full Text].
Cunningham KA, Beagley KW. Male genital tract chlamydial infection: implications for pathology and infertility. Biol Reprod. Aug 2008;79(2):180-9. [Medline].
Frenkl T, Potts J. Sexually Transmitted Infections: Part II - Associated Vaginitides and Urethritides. AUA Update Series. 2006;25:17-9.
Isselbacher HK, Braunwald E, Wilson JD et al, eds. Harrison's Principles of Internal Medicine. 13th ed. New York, NY: McGraw-Hill; 1994.
Jensen JS, Bradshaw CS, Tabrizi SN, Fairley CK, Hamasuna R. Azithromycin Treatment Failure in Mycoplasma genitalium-Positive Patients with Nongonococcal Urethritis Is Associated with Induced Macrolide Resistance. Clin Infect Dis. Dec 15 2008;47(12):1546-1553. [Medline].
Kataria RK, Brent LH. Spondyloarthropathies. Am Fam Physician. Jun 15 2004;69(12):2853-60. [Medline].
Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 5th ed. New York, NY: Churchill Livingstone; 1998.
National Institute of Allergy and Infectious Diseases. Fact Sheet. STD Statistics. Bethesda, Md: National Institutes of Health; December 1998. [Full Text].
Newman LM, Moran JS, Workowski KA. Update on the management of gonorrhea in adults in the United States. Clin Infect Dis. Apr 1 2007;44 Suppl 3:S84-101. [Medline].
Ochsendorf FR. Sexually transmitted infections: impact on male fertility. Andrologia. Apr 2008;40(2):72-5. [Medline].
[Guideline] Workowski KA, Levine WC. Selected topics from the Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines 2002. HIV Clin Trials. Sep-Oct 2002;3(5):421-33. [Medline]. [Full Text].

